Brazil at a glance
- Population
- 212.8 million 2025
- Life expectancy at birth
- 76.0 years, 2024
- People aged 65 and over
- 11.5 % of people, 2025
- Health spending per person
- 1,010 US$ per person, 2023
- Doctors
- 2.36 per 1,000 people, 2023
Updated
Reviewed by Vidhi Upadhyay
Brazil Oral Rehydration Solutions Market Industry Trends and Forecast to 2034: Segmented by (Product, User, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$31.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $35.2 Mn | — | — |
| 2025 (base) | $37.7 Mn | +$2.5 Mn | — |
| 2026 (forecast) | $40.3 Mn | +$2.6 Mn | +7% |
| 2027 (forecast) | $43.1 Mn | +$2.8 Mn | +14.5% |
| 2028 (forecast) | $46.1 Mn | +$3.0 Mn | +22.5% |
| 2029 (forecast) | $49.4 Mn | +$3.2 Mn | +31.1% |
| 2030 (forecast) | $52.8 Mn | +$3.5 Mn | +40.3% |
| 2031 (forecast) | $56.5 Mn | +$3.7 Mn | +50.1% |
| 2032 (forecast) | $60.5 Mn | +$4.0 Mn | +60.6% |
| 2033 (forecast) | $64.7 Mn | +$4.2 Mn | +71.8% |
| 2034 (forecast) | $69.2 Mn | +$4.5 Mn | +83.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $37.7 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $69.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Also called | Oral Rehydration Salts (ORS) |
| Segments | Product, user and distribution channel (see all) |
| Key players | Abbott Laboratories, Johnson & Johnson, Cipla Inc., FDC Limited, Prestige Consumer Healthcare (see all) |
| Regulator in Brazil | ANVISASource: ANVISA. Checked 14 Nov 2026.Source: ANVISA. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Oral rehydration solutions are salt and sugar mixes that treat dehydration from diarrhoea, saving many children's lives.
Key segments of the oral Rehydration Solutions market include product (Powders, Ready-to-Drink and Tablets) and user (Children, Adults and Travelers).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the oral Rehydration Solutions market.
Digital tools for community health, local manufacturing and public-private partnerships give the oral Rehydration Solutions market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the oral Rehydration Solutions market.
The oral Rehydration Solutions market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale.[1] Food supplements follow their own ANVISA rules, with lists of allowed ingredients and claims.[1]
[1] ANVISA. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern oral Rehydration Solutions products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Brazil.
What doctors and scientists are doing in Oral Rehydration Solutions right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Brazil · 2 shared keywords
Brazil · 2 shared keywords
Brazil · 2 shared keywords
Brazil · 2 shared keywords
Brazil · 2 shared keywords
Brazil · 2 shared keywords
Medical Devices · Brazil
Medical Devices · Brazil
Pharmaceuticals · Brazil
Pharmaceuticals · Brazil
Medical Devices · Brazil
Healthcare Services · Brazil